Leadership
Morris Birnbaum, MD, PhD
Global leader in metabolism, obesity, and incretins. Former SVP and CSO of Pfizer Internal Medicine, and sat on the company's Worldwide R&D Leadership Team. Former Harvard and Penn researcher, Howard Hughes Investigator.
LinkedIn ↗︎
Lindsay Holden, MBA
Co-founded and leads operations for CASPR. Former VC, investor, and advisor. Co-founder and CEO of Long Game, consumer fintech startup acquired by Truist in 2022, then SVP and Head of Truist Foundry.
LinkedIn ↗︎
Nicholas Reville
Successful exited tech startup founder and NGO director. Co-founded and directs the Center for Addiction Science, Policy, and Research (CASPR), leaders in GLP-1 SUD strategies. International speaker on addiction medicine and policy.
LinkedIn ↗︎
Oved Amitay, MSc
Pharmacologist and drug-development executive who has led nonprofit, biotech, and diagnostic organizations. Has brought 9 drugs through to market. President & CEO of Solve M.E., Chief Business Officer of Centogene AG and President & COO of Arrett Neuroscience.
LinkedIn ↗︎
Kate Tallman
Biotech commercial experience from over 25 years in business development, program management, market access and sales roles. Negotiated over 100 R&D collaboration agreements including Pfizer, Roche and Novartis.
LinkedIn ↗︎KEY PARTNERS
Janet Ransom, PhD
Founder and President of Fast-Track, a specialty CRO with more experience in AUD clinical trials than any other organization. She has led dozens of interactions with the FDA's addiction review division and spent 19 years as Project Director on NIAAA contracts and multiple NIDA-funded programs.
LinkedIn ↗︎
Nick Davies, MSc
Founder and Managing Partner of Verta Life Sciences, leading operations across 26+ countries, helping clients scale manufacturing, resolve global supply issues, and bring therapies to market. 30 years of experience in product launches, supply chain strategy, and regulatory readiness for biotech firms.
LinkedIn ↗︎